Overview
The Biotin-Corticotropin Releasing Factor, or Biotin-CRF, is a specialized peptide designed for research on the hypothalamic-pituitary-adrenocortical axis. CRF plays a crucial role in regulating stress response and has implications for various physiological processes, including neuroendocrine regulation, cardiovascular health, and immune function. This biotin-labeled variant is a valuable tool for scientists studying stress-related disorders, offering a reliable means of tracking protein interactions and cellular activities.
Key Features
- Biotin-labeled for enhanced detection in various assays.
- Critical for research on stress responses and the endocrine system.
- Available in a 0.5 mg quantity, ideal for multiple experimental setups.
- Compatible with several detection platforms, including ELISA and western blotting.
- Manufactured to high standards, ensuring consistency and reliability.
Specifications
| Property | Details |
|---|---|
| Product Name | Biotin-Corticotropin Releasing Factor |
| Category | Peptides |
| Quantity | 0.5 mg |
| Species | Human, Rat |
FAQ
What is the purpose of Biotin-CRF?
Biotin-CRF is primarily used in research to study stress responses and the functioning of the hypothalamic-pituitary-adrenocortical axis. Researchers utilize this peptide to explore its effects on various physiological pathways.
How can I use Biotin-CRF in my experiments?
Biotin-CRF can be used in multiple assays, including ELISA and western blotting, for detecting protein interactions and studying cellular mechanisms related to stress and endocrine responses.
Is Biotin-CRF suitable for use in both human and rat studies?
Yes, the Biotin-Corticotropin Releasing Factor is designed for both human and rat studies, making it versatile for comparative research in different species.
To enhance your research outcomes, consider exploring other related products like the PKG Substrate and our wide range of peptides. For additional fluorescent labeling options, check out the CREBtide offering.




Reviews
There are no reviews yet.